ONCOReveal Multi-Cancer Panel

The ONCOReveal Multi-Cancer Panel is a comprehensive targeted approach to multiple gene regions across numerous solid tumor cancer types. The ONCOReveal Multi-Cancer Panel targets a total of 56 genes.*

Benefits:

  • Requires as little as 2.5 ng of input DNA
  • Detection of 1% allele frequency in somatic cancers
  • Single sample / single well assay technology for enhanced sensitivity
  • Automatable sample processing
Multi-Cancer Tumor Panel Target Genes (56 in total)
ABL1 CSF1R FGFR1 HNF1A KRAS NTRK1 ROS1
AKT1 CTNNB1 FGFR2 HRAS MAP2K1 PDGFRA SMAD4
ALK DDR2 FGFR3 IDH1 MET PIK3CA SMARCB1
APC EGFR FLT3 IDH2 MLH1 PTEN SMO
ATM ERBB2 FOXL2 JAK2 MPL PTPN11 SRC
BRAF ERBB4 GNA11 JAK3 NOTCH1 RAC1 STK11
CDH1 EZH2 GNAQ KDR NPM1 RB1 TP53
CDKN2A FBXW7 GNAS KIT NRAS RET VHL
 

*The ONCOReveal Multi-Cancer Panel content is based on data across consortia and organizations such as the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), the National Comprehensive Cancer Network (NCCN), and Catalog Of Somatic Mutations In Cancer (COSMIC) database, in addition to ongoing clinical trials.